Paige.ai

Paige is a digital pathology AI company founded in 2017 in New York as a Memorial Sloan Kettering Cancer Center spinout by Thomas Fuchs and colleagues. Its AI platform supports pathologists in cancer diagnosis with FDA-cleared decision-support tools.

Paige's FullFocus slide viewer and Paige Prostate Detect were the first FDA-authorized AI applications for digital pathology in the United States. The company serves reference labs, health systems, and biopharma partners.

Paige has raised approximately $215 million, including a $100 million Series C led by Casdin Capital and Johnson & Johnson Innovation – JJDC. Leo Grady, formerly CEO of HeartFlow, joined as CEO in 2019.